: November 14, 2017
Minimus Spine signs first European Distribution Agreement with MOSS S.p.A. and completes initial stocking order.
: August 18, 2017
Dr. Alexis Kelekis to present update on European study at CIRSE 2017.
: February 20, 2017
Jeffrey R. Binder appointed to Minimus Spine's board of directors.
: November 14, 2016
Minimus Spine enrolls 30th patient in European study comparing Triojection® to discectomy.
: September 15, 2015
Minimus Spine initiates European study comparing Triojection® to discectomy.
: March 6, 2015
Minimus Spine announces another key Triojection® patent issued by USPTO.
: December 9, 2014
Minimus Spine announces first ever cases with Triojection® System.
: August 4, 2014
Minimus Spine secures ISO 13485 and EC Certification for Triojection™ System.
: December 10, 2013
Minimus Spine closes deal with Texas for $1.75M.
: October 8, 2013
Minimus Spine secures two new patents from USPTO.
: November 5, 2012
Minimus Spine Raises Over $500k in Angel Financing for Triojection and Appoints Wes Johnson to Board of Directors.
: August 29, 2011
Minimus Spine Receives Notice of Allowance for its Syringe Designed to Produce Ozone for Spinal Injection.
: October 1, 2009
Minimus Spine Granted its First US Patent for Spinal Ozone
Read a 2008 interview with David Hooper of Minimus Spine